Evidence map›Paper›PMID 29605262›Full record

ArticleJournal of pediatric surgery2020

A novel image-based system for risk stratification in patients with desmoplastic small round cell tumor.

James A Saltsman, Anita P Price, Debra A Goldman, William J Hammond, Enrico Danzer, Heather Magnan, Emily Slotkin, William D Tap, Todd E Heaton, Shakeel Modak and 1 more

Abstract read
In one paragraph

Article in Journal of pediatric surgery, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

James A SaltsmanPediatric Surgical Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY.
Anita P PriceDepartment of Radiology, Memorial Sloan Kettering Cancer Center, New York, NY.
Debra A GoldmanDepartment of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY.
William J HammondPediatric Surgical Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY.
Enrico DanzerPediatric Surgical Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY.
Heather MagnanDepartment of Pediatrics, Memorial Sloan Kettering Cancer Center, New York, NY.
Emily SlotkinDepartment of Pediatrics, Memorial Sloan Kettering Cancer Center, New York, NY.
William D TapSarcoma Medical Oncology Service, Department of Medical Oncology, Memorial Sloan Kettering Cancer Center, New York, NY.
Todd E HeatonPediatric Surgical Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY.
Shakeel ModakDepartment of Pediatrics, Memorial Sloan Kettering Cancer Center, New York, NY.
Michael P LaQuagliaPediatric Surgical Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY. Electronic address: laquaglm@mskcc.org.

Funding

X-RAY CRYSTALLOGRAPHYP30CA008748 · NCI · SLOAN-KETTERING INSTITUTE FOR CANCER RES · PI Hongbiao Carl Lekaye · 1985 to 2026
$347.4M
NCI NIH HHS P30 CA008748
6 · The paper itself

Abstract

backgroundDesmoplastic small round cell tumor (DSRCT) is an aggressive soft tissue sarcoma affecting children and young adults with 5-year overall survival (OS) of approximately 20%. Despite generally poor prognosis, long-term survival does occur. However, no evidence-based system exists to risk-stratify patients at diagnosis.

methodsWe retrospectively reviewed all DSRCT cases diagnosed at our institution between January 2000 and September 2016. Demographics, diagnostic imaging, and clinical data were reviewed. Univariate and multivariate Cox proportional hazard modeling was used to evaluate associations between imaging characteristics and OS.

resultsThere were 130 patients (85% male; median age at presentation: 21.2 years) with confirmed DSRCT and sufficient imaging and clinical information for analysis. Median 5-year OS was 28% (95% CI: 19%-37%). In univariate analysis, shorter OS was associated with presence of liver lesions (hazard ratio [HR] 2.1, 95% CI: 1.28-3.45), chest lesions (HR 1.86, 95% CI: 1.11-3.1), and ascites (HR 1.69, 95% CI: 1.06-2.7). In multivariate analysis, liver involvement and ascites were predictive and were used to stratify risk (intermediate=no liver involvement or ascites; high=either liver involvement or ascites; very high=both liver involvement and ascites). Intermediate-risk patients had a 5-year survival of 61% (95% CI: 40%-76%) versus 16% (95% CI: 6%-29%) among high-risk patients and 8% (95% CI: 1%-29%) among very high risk patients.

conclusionPatients with DSRCT can be risk-stratified at diagnosis based on specific imaging characteristics. TYPE OF STUDY: Retrospective study with no comparison group. LEVEL OF EVIDENCE: Level IV.

Indexed as

Desmoplastic Small Round Cell TumorAdultFemaleHumansLiver NeoplasmsMaleRetrospective StudiesRisk AssessmentYoung AdultCancer stagingDesmoplastic small round cell tumorDSRCTPediatric surgerySarcomaSurgical oncology

Identifiers

PMID29605262
PMCPMC6126997

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.